摘要
目的:探讨铥激光剥橘式前列腺切除术对良性前列腺增生(BPH)患者性功能的影响。方法:选取我院120例采用铥激光剥橘式前列腺切除术进行治疗且尚有性生活的BPH患者为研究对象,随访并分析患者术前、术后6个月、12个月国际前列腺症状评分(IPSS)、生活质量评分(QOL)、残余尿量(PVR)、最大尿流率(Qmax)指标,使用国际勃起功能指数-5(IIEF-5)评价患者勃起情况,并记录患者射精疼痛、精量减少及逆行射精发生率。结果:术后6、12个月IPSS评分、QOL评分、PVR较术前均显著下降,Qmax较术前显著上升(P<0.05);术前和术后6、12个月的IIEF-5评分比较差异无统计学意义(P>0.05),勃起功能无明显下降。术后6、12个月精量减少、逆行射精发生率与术前比较差异有统计学意义(P<0.05);术后6、12个月射精疼痛发生率与术前比较差异无统计学意义(P>0.05)。结论:铥激光剥橘式前列腺切除术对患者性功能的影响较少。铥激光本身属性以及本术式独特的切除方法,对性功能具有一定的保护作用。
Objective:To evaluate the impact of thulium laser resection of the prostate-tangerine technique(TmLRP-TT)on sexual function of patients with benign prostatic hyperplasia(BPH).Method:BPH patients in our hospital from 2015 to 2016 were selected and treated with TmLRP-TT.IPSS,QOL,PVR,Qmax were recorded to evaluate the outcome of the operation,the sexual functions were evaluated with IIEF-5 before and after the operation and the incidence of painful ejaculation and retrograde ejaculation(RE)were counted.Result:Compared with the preoperative period,postoperative QOL,IPSS,PVR significantly decreased 6 and 12 months after surgery,while Qmaxsignificantly increased(P<0.05).No significant difference in erectile function before and after surgery were observed(P>0.05).The prevalence of postoperative RE increased and the ejaculatory volume reduced evidently after treatment(P<0.05),while difference in the incidence of painful ejaculation before and after surgery was not statistically significant(P>0.05).Conclusion:TmLRP-TT has little effect on the sexual function of BPH patients.The characteristic of thulium laser and the unique operation can provide protection for sexual function.
引文
1 夏术阶,张沂南,鲁军,等.铥激光"剥橘"式切除术治疗良性前列腺增生症[J].中华医学杂志,2005,85(45):3225-3228.
2 Xia S J.Two-micron(thulium)laser resection of the prostate-tangerine technique:a new method for BPHtreatment[J].Asian J Androl,2009,11(3):277-281.
3 van Rij S,Gilling P.Recent advances in treatment for Benign Prostatic Hyperplasia[J].F1000Res,2015.
4 Carmignani L,Bozzini G,Macchi A,et al.Sexual outcome of patients undergoing thulium laser enucleation of the prostate for benign prostatic hyperplasia[J].Asian J Androl,2015,17(5):802-806.
5 Oelke M,Bachmann A,Descazeaud A,et al.European Association of Urology.EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction[J].Eur Urol,2013,64(1):118-140.
6 邵晋凯,王毓斌,吕永安,等.120W2μm激光前列腺剜除术治疗良性前列腺增生[J].临床泌尿外科杂志,2011,26(8):603-605.
7 Xia S J,Zhuo J,Sun X W,et al.Thulium laser versus standard transurethral resection of the prostate:a randomized prospective trial[J].Eur Urol,2008,53(2):382-389.
8孙江江,杨龙,王宝龙,等.120W/2μm铥激光前列腺汽化剜除术治疗BPH的疗效观察[J].临床泌尿外科杂志,2013,28(4):273-275.
9 Nolan M W,Marolf A J,Ehrhart E J,et al.Pudendal nerve and internal pudendal artery damage may contribute to radiation-induced erectile dysfunction[J].Int JRadiat Oncol Biol Phys,2015,91(4):796-806.
10 Bach T,Huck N,Wezel F,et al.70vs 120 Wthulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia:a systematic ex-vivo evaluation[J].BJU Int,2010,106(3):368-372.
11 Spatafora S,Casarico A,Fandella A,et al.Evidencebased guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy:updated summary from AURO it[J].Ther Adv Urol,2012,4(6):279-301.
12 卓见,顾韧责,赵福军,等.2微米铥激光前列腺切除术对性功能的影响[J].微创泌尿外科杂志,2013,2(1):68-70.
13 Frieben R W,Lin H C,Hinh P P,et al.The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function:a systematic review[J].Asian J Androl,2010,12(4):500-508.
14 Choi H S,Kim D J,Kim D S,et al.Factors affecting the improvement of the initial peak urinary flow rate after transurethral resection of the prostate orphotoselective vaporization of the prostate for treating benign prostatic hyperplasia[J].Int Neurourol J,2011,15(1):35-40.
15 Ronzoni G,De Vecchis M.Preservation of anterograde ejaculation after transurethral resection of both the prostate and bladder neck[J].Br J Urol,2015,81(6):830-833.